TBG Diagnostics Ltd (TDL):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TBG Diagnostics Ltd (TDL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10134
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include nucleic acid extraction kits, HLA SBT typing kits, HPA genotyping kits, automated pipetting system, and gel electrophoresis. It serves clinical laboratories of hospitals and independent reference labs, blood centers and bone marrow registry labs worldwide. It has research and development (R&D) facilities in the US, Taiwan and China and a manufacturing facility in Xiamen, China. The company has collaboration and product licensing agreements with various pharmaceutical companies and others to expand market presence and product portfolio. TBG Diagnostics is headquartered in Greenslopes, Queensland, Australia.

TBG Diagnostics Ltd (TDL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TBG Diagnostics Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Progen Pharma Enters Into Licensing Agreement With Medigen Biotech For PG545 11
Beta Therapeutics Enters into Licensing Agreement with Progen Pharma 12
Equity Offering 13
Progen Pharma Raises USD9 Million in Public Offering of Shares 13
Progen Pharma Completes Rights Issue Of Common Stock For US$5.4 Million 14
Acquisition 15
Zucero Therapeutics Acquires Progen PG500 Series from TBG Diagnostics 15
TBG Diagnostics to Acquire 51% Stake in RBC Biosciences for USD4 Million 16
TBG Diagnostics Ltd – Key Competitors 17
TBG Diagnostics Ltd – Key Employees 18
TBG Diagnostics Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Legal and Regulatory 20
Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TBG Diagnostics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
TBG Diagnostics Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Progen Pharma Enters Into Licensing Agreement With Medigen Biotech For PG545 11
Beta Therapeutics Enters into Licensing Agreement with Progen Pharma 12
Progen Pharma Raises USD9 Million in Public Offering of Shares 13
Progen Pharma Completes Rights Issue Of Common Stock For US$5.4 Million 14
Zucero Therapeutics Acquires Progen PG500 Series from TBG Diagnostics 15
TBG Diagnostics to Acquire 51% Stake in RBC Biosciences for USD4 Million 16
TBG Diagnostics Ltd, Key Competitors 17
TBG Diagnostics Ltd, Key Employees 18
TBG Diagnostics Ltd, Other Locations 19
TBG Diagnostics Ltd, Subsidiaries 19

List of Figures
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TBG Diagnostics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TBG Diagnostics Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TBG Diagnostics Ltd (TDL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Spineway SAS (ALSPW):企業の財務・戦略的SWOT分析
    Summary Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc d …
  • Ube Industries Ltd (4208):企業の財務・戦略的SWOT分析
    Ube Industries Ltd (4208) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dominion Energy Inc (D):企業の財務・戦略的SWOT分析
    Dominion Energy Inc (D) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Prescient Therapeutics Ltd (PTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company’s lead drug candidate includes PTX-200, a potent small molecule inhibitor of the …
  • Just Eat Plc
    Just Eat Plc - Strategy, SWOT and Corporate Finance Report Summary Just Eat Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Mitsui-Soko Holdings Co Ltd (9302):企業の財務・戦略的SWOT分析
    Mitsui-Soko Holdings Co Ltd (9302) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • HCA Healthcare, Inc.:企業の戦略・SWOT・財務分析
    HCA Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary HCA Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • RHI AG:戦略・SWOT・企業財務分析
    RHI AG - Strategy, SWOT and Corporate Finance Report Summary RHI AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Somnomed Ltd (SOM)-医療機器分野:企業M&A・提携分析
    Summary Somnomed Ltd (SomnoMed) is medical device company that develops produces, commercializes and sells device for the oral treatment of sleep related disorders. The company’s products include somnodent, an oral appliance for obstructive sleep apnea; and somnobrux, a mouthguard that protects pati …
  • Philip Morris International Inc (PM):企業の財務・戦略的SWOT分析
    Philip Morris International Inc (PM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Awarepoint Corp:医療機器:M&Aディール及び事業提携情報
    Summary Awarepoint Corp (Awarepoint) is a healthcare technology company that provides real time location system. The company offers technology, software and managed services. It provides location software packages for mobile phones and other electronics. Awarepoint’s software packages provide patien …
  • America Movil, SA DE C.V.:企業の戦略・SWOT・財務情報
    America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report Summary America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • SM Energy Company:企業の戦略・SWOT・財務分析
    SM Energy Company - Strategy, SWOT and Corporate Finance Report Summary SM Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Colgate-Palmolive (India) Ltd:企業の戦略・SWOT・財務情報
    Colgate-Palmolive (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Colgate-Palmolive (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Volkswagen AG:戦略・SWOT・企業財務分析
    Volkswagen AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Talisman Mining Ltd (TLM):企業の財務・戦略的SWOT分析
    Summary Talisman Mining Ltd (Talisman Mining) is a mining and mineral exploration and development company. The company explores for copper-gold, base metal, and gold deposits. Its projects portfolio includes Springfield project, Sinclair Nickel Project, Milgun Project, Halloween and Halloween West J …
  • CUNA Mutual Group:企業の戦略・SWOT・財務情報
    CUNA Mutual Group - Strategy, SWOT and Corporate Finance Report Summary CUNA Mutual Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Dai Nippon Printing Co., Ltd.
    Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Penn Virginia Corp (PVAC):企業の財務・戦略的SWOT分析
    Penn Virginia Corp (PVAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆